News
Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...
It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...
Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across ...
9h
Everyday Health on MSN5 Ways to Manage Psoriatic Arthritis–Related Brain Fog - MSNAnother potential cause of brain fog: “If you have an autoimmune disease such as psoriatic arthritis, you’re more likely to have fibromyalgia,” says Anca Askanase, MD, a professor of ...
The pharma began its outreach to the HS community well before securing Bimzelx’s approval in the indication. In the spring of ...
Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...
Certolizumab Pegol is indicated for the treatment of patients with rheumatoid arthritis, polyarticular juvenile idiopathic ...
AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...
Lupin & Zentiva ink licensing and supply agreement for commercializing biosimilar Certolizumab Pegol
Lupin & Zentiva ink licensing and supply agreement for commercializing biosimilar Certolizumab Pegol: Our Bureau, Mumbai Wednesday, July 9, 2025, 16:20 Hrs [IST] Global Pharma maj ...
Lupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants Zentiva commercialisation rights outside the US and Canada, ...
3h
Cornwall Live on MSNDWP's £748 monthly boost may be accessible to specific people with muscle problemsTo be eligible for the Personal Independence Payment (PIP), you need a health condition or disability that satisfies certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results